Phenylalanine metabolism and tetrahydrobiopterin bio-availability in COVID-19 and HIV

Thumbnail Image

Files

Mason_Phenylalanine_2023.pdf (4.77 MB)
Mason_PhenylalanineSuppl1_2023.pdf (63.86 KB)
Mason_PhenylalanineSuppl2_2023.pdf (76.47 KB)

Date

2023-03

Authors

Mason, Shayne
Van Reenen, Mari
Lindeque, Zander
Louw, Roan

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Please read abstract in article.

Description

Supporting information file S1: Study Models
Supporting information file S2: Phenylalanine metabolism and tetrahydrobiopterin bio-availability in COVID-19 and HIV data
DATA AVAILABILITY STATEMENT: Data will be made available on request.

Keywords

Phenylalanine, Tetrahydrobiopterin (BH4), Metabolism, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), COVID-19 pandemic, Human immunodeficiency virus (HIV), SDG-03: Good health and well-being

Sustainable Development Goals

Citation

Mason, S., Van Reenen, M., Rossouw, T. et al. 2023, 'Phenylalanine metabolism and tetrahydrobiopterin bio-availability in COVID-19 and HIV'. Heliyon, vol. 9, no. 4, art. e15010, doi : 10.1016/j.heliyon.2023.e15010.

URI

http://hdl.handle.net/2263/92910

Collections

Research Articles (Immunology)
Research Articles (University of Pretoria)
Full item page